X4 Pharmaceuticals
NeutroKOL Intelligence Platform

Access Required

Confidential KOL intelligence for the neutropenia therapeutic area.

Access is restricted to authorized @heklaventures.com and @x4pharma.com email addresses. Please sign in with your organization email.
Incorrect password. Try again.
X4 Pharmaceuticals — NeutroKOL Platform

Chronic Neutropenia — Global KOL Intelligence

30 KOLs · 11 countries · 23 tabs · PubMed-validated · Sunshine Act data · engagement strategies · competitive intel

X4
Prepared by Hekla Ventures
NeutroKOL Platform · Prepared by Hekla Ventures for X4 Pharmaceuticals
Sources: PubMed Entrez API (April 2026), NIH RePORTER, SCNIR, ASH, EHA, ASPHO, ClinicalTrials.gov, CMS Open Payments (2024), X4 Pharma SEC filings, EuNet-INNOCHRON
Co-author counts = PubMed "[A] AND [B] AND neutropenia". Pub velocity = PubMed "[Author] AND neutropenia AND [year]". Grants = NIH RePORTER API. Sunshine Act = CMS bulk CSV.